IMA

IMAGENEBIO INC

IMA·45175G207·US·Common Stock·Healthcare - Biotechnology-Activist

IMA (IMAGENEBIO INC) is held by 24 institutional investors as of Q1 2026. Largest holders: RTW INVESTMENTS, LP ($1.7M), VANGUARD CAPITAL MANAGEMENT LLC ($1.6M), BlackRock, Inc. ($646,070). Net institutional sentiment: Bullish.

24
Holders
Avg rating(5 Elite)
$6.4M
Total Value
73% (27)
Fund Consensus
16 buying - 6 selling
IMASmart Money Verdict
View all
Held by 24 funds
5 elite
Who's Trading
ActivistBLBVF PARTNERS L P/IL9.9%May 15, 2026
ActivistBOBlue Owl Capital Holdings LP8.5%May 14, 2026
ActivistOAORBIMED ADVISORS LLC13.1%Apr 29, 2026
ActivistOVOmega Fund VI, L.P.8.4%Apr 21, 2026
ActivistTETrails Edge Capital Partners, LP9.9%Apr 21, 2026
ActivistDTDeep Track Capital, LP0.0%Feb 13, 2026
ActivistFUFunicular Funds, LP5.8%Jan 6, 2026
InsiderSPSLATTERY JOSEPH PBuy $96KDec 24, 2025
InsiderSOStampacchia OtelloBuy $8.0MJul 25, 2025
InsiderBPBonita David PBuy $2.5MJul 25, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
334,445$1.7M0.0%-23.25%
0
New
325,155$1.6M0.0%-3.27%
39
Decreased
129,214(-1.8%)$646,0700.0%-19.52%
0
Increased
124,345(+43.8%)$621,7250.0%-18.10%
33
Increased
81,696(+23.6%)$408,4800.0%-17.79%
29
Unchanged
66,666$333,3300.0%-23.25%
0
Increased
59,929(+10.7%)$299,6720.0%-21.02%
18
Increased
34,884(+1.9%)$165,6990.0%-16.66%
23
New
27,286$136,4300.0%-3.27%
34
Increased
26,663(+42.4%)$133,3150.0%-17.96%
30
Increased
18,339(+70.3%)$91,6950.0%-12.30%
22
Increased
15,112(+24.1%)$75,5600.0%-20.04%
26
Decreased
13,210(-11.3%)$66,0500.0%-16.88%
0
Increased
11,458(+4.6%)$57,2900.0%-16.36%
15
Increased
10,959(+1.5%)$54,7950.0%-19.15%
14
Increased
5,428(+9.4%)$27,1400.0%-21.64%
14
Unchanged
1,000$5,0000.0%-16.88%
0
New
602$3,0100.0%-3.27%
20
Increased
293(+318.6%)$1,4650.0%-8.94%
12
New
224$1,1200.0%-3.27%
17

Showing 1-20 of 27

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used